Literature DB >> 19217598

Sealants after axillary lymph node dissection for breast cancer: good intentions but bad results.

Panagiotis Taflampas1, Elias Sanidas, Manousos Christodoulakis, John Askoxylakis, John Melissas, Dimitrios D Tsiftsis.   

Abstract

BACKGROUND: This study was conducted to evaluate the effect of 2 surgical sealants on postsurgical drainage and lymphocele formation after axillary surgery for breast cancer.
METHODS: This was a prospective, randomized study. Seventy-seven consecutive patients with breast cancer were included and randomized into a control group (18F vacuum drain) and 2 study groups (18F vacuum drain plus COSEAL or BioGlue).
RESULTS: The 3 groups were matched. Neither postsurgical drainage nor time to drain removal was affected by the use of either of the 2 sealants. Although no statistically significant difference in lymphocele formation and wound infection was noted, complications caused by intense foreign-body reaction that led to surgical intervention occurred in both study groups. COMMENTS: The use of surgical sealants is not recommended after axillary lymph node dissection for breast cancer. Complications of their use may lead to reoperation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19217598     DOI: 10.1016/j.amjsurg.2008.06.043

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  4 in total

Review 1.  Fibrin glue instillation under skin flaps to prevent seroma-related morbidity following breast and axillary surgery.

Authors:  Muhammad S Sajid; Kristian H Hutson; Ignazio F Rapisarda; Riccardo Bonomi
Journal:  Cochrane Database Syst Rev       Date:  2013-05-31

2.  A Breast Reconstruction Using a Breast Prosthesis and Capsular Flap for a Lymphocele Patient.

Authors:  Tomoyuki Yano; Daisuke Shimizu; Yoshitaka Ishii; Osamu Ito; Masayuki Sawaizumi
Journal:  Plast Reconstr Surg Glob Open       Date:  2017-10-24

3.  A model for the early identification of sentinel lymph node metastasis in patients with breast cancer based on contrast-enhanced ultrasound and clinical features.

Authors:  Juan Xu; Junzhi Li
Journal:  Oncol Lett       Date:  2022-09-08       Impact factor: 3.111

4.  Evaluation of the Effects of Pasireotide LAR Administration on Lymphocele Prevention after Axillary Node Dissection for Breast Cancer: Results of a Randomized Non-Comparative Phase 2 Study.

Authors:  Elisabeth Chéreau; Catherine Uzan; Emmanuelle Boutmy-Deslandes; Sarah Zohar; Corinne Bézu; Chafika Mazouni; Jean-Rémi Garbay; Emile Daraï; Roman Rouzier
Journal:  PLoS One       Date:  2016-06-09       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.